News
AbbVie Inc. (NYSE: ABBV) is reportedly negotiating the acquisition of Gilgamesh Pharmaceuticals, a privately held mental ...
Asianet Newsable on MSN10m
AbbVie Retail Traders Remain Wary Amid Report Of $1B Gilgamesh Deal To Boost Mental Health PipelineThe potential acquisition follows a 2023 licensing partnership between the two companies and comes after Gilgamesh reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback